Clinical Trials

Open to Enrollment

  • ALCMI-007 A Prospective Biospecimen Collection Study from Patients with ROS1-Fusion Positive Tumors for Cell Line Generation 
  • Blood Collection from Patients to Evaluate for Whole Parathyroid Hormone Measurement Differences Using Various Specimen Collection Tubes
  • ALCMI-006 A Prospective Biospecimen Collection Study from Patients with ROS1-Fusion Positive Tumors
  • Evaluation of a Collection of Archival Tumor Tissue Specimens from Patients Diagnosed with Infantile Fibrosarcoma to Support the Analytical Validation of Diagnostic Assays – Principal Investigator
  • Blood Collection from Patients to Evaluate for TSH, Testosterone and βHCG Measurement Differences Using Various Specimen Collection Tubes
  • ALCMI-001 Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network 
  • ALCMI-002 INHERIT EGFR - Investigating Hereditary Risk from T790M: A multi-centered study to identify and characterize individuals carrying germline EGFR mutations

Closed to Enrollment

  •  A Prospective Longitudinal Study of CA 19-9 as an Aid in Monitoring Disease in Patients with Pancreatic Cancer
  • A Prospective Longitudinal Study of CA 15-3 as an Aid in Monitoring Recurrence of Progressive Disease in Patients With Breast Cancer
  • ALCMI-003 Genomics of Young Lung Cancer (GoYLC) Study

Completed Trials

  •  A Blood Collection from Patients Prescribed a Laboratory Test to Screen for Syphilis
  • A Prospective Collection of Peripheral Blood Specimens to Study Fertility in Healthy, Premenopausal Women
  • A Blood Collection from Patients Presenting in the Emergency Department and Prescribed a Brain Natriuretic Peptide Laboratory Test
  • A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Glucose in Healthy Individuals
  • A Prospective Collection of Peripheral Blood Specimens to Study Vitamin D in Healthy Children
  • A Prospective Collection of Peripheral Blood Specimens to Study Vitamin D in Healthy Individuals
  • Clinical Specimen Collection Protocol: Oncology Study
  • Multiple Myeloma Research Consortium Biobank
  • MMRC: Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution
  • Phase II: Low dose docetaxel, estramustine and thalidomide followed by maintenance thalidomide for the treatment of hormone refractory prostate cancer (HRPC). 
  • Radiation Therapy in Treating Patients With Stage II of Stage III Prostate Cancer
  • Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
  • Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
  • A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
  • Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin’s Lymphoma Who Have Previously Failed Rituxan Treatments